Tag: Johnson & Johnson

J&J Acquires Auris Health for $3.4b

Auris Health’s Robotic Platform Expands Johnson & Johnson’s Digital Surgery Portfolio. Focused on creating the next frontier of surgery, Johnson & Johnson, announced that Ethicon, Inc., ent...

Philogen and Janssen Discover New Molecular Therapy

Philogen S.p.A., a privately-owned biotechnology company, today announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Jans...

AbbVie and J&J’s Pancreatic Cancer Drug Failed Trial

AbbVie and Johnson & Johnson’s hopes of adding pancreatic cancer to the repertoire of oncology blockbuster Imbruvica has hit a snag. In the phase III RESOLVE trial, Imbruvica (ibrutinib) was no...

J&J’s baby powder will be Tested by CDSCO

The Indian top drug regulator, the CDSCO, drew samples of Johnson and Johnson's baby powder from the company's Baddi plant in Himachal Pradesh on Wednesday amid reports that the product allegedly cont...

Johnson & Johnson launches a new vaccines facility in the Netherlands

Johnson & Johnson unveiled a new vaccines launch facility that represents a significant investment in novel vaccines development, global health and security, and pandemic preparedness efforts.

Johnson & Johnson Institute opened a new facility in China

The Johnson & Johnson Institute, a leader in professional medical education, announced the opening of its new facility in Beijing. It represents the largest investment in the global relaunch of the Johnson & Johnson institutes.

Janssen Biotech will buy BeneVir Biopharm

Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, will acquire BeneVir Biopharm, a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies.

Johnson & Johnson Innovation creates a research incubator in Belgium

test tubes
The Belgium-based JLINX incubator – a collaboration launched in March 2016 between Janssen Pharmaceutica NV and Bioqube Ventures – will become part of the global Johnson & Johnson Innovation network

Johnson & Johnson launches its innovation hub in China

johnson & johnson
Johnson & Johnson Innovation announced a collaboration with the Shanghai Municipal Government and Shanghai Pharma Engine Company Ltd

Janssen and Zymeworks become partners in drug development

drug development
Zymeworks Inc announced it has executed a licensing agreement with Janssen Biotech

Johnson & Johnson sets up partnering office at Seoul Bio Hub

Global pharmaceutical and biohealth firm Johnson & Johnson opened a new partnering office in Seoul to support emerging entrepreneurs and biotech businesses

Janssen localizes the manufacturing of Imbruvik in Russia

janssen j&j
Janssen confirmed its intention to localize the portfolio of innovative drugs for the treatment of malignant blood diseases, including the localization of Imbruvik

Johnson & Johnson set up partnership with Indian Microbial Technology Institute

Johnson & Johnson Private Limited announced a new partnership with the Institute of Microbial Technology to unlock the potential of Indian science and help accelerate the discovery of innovative new treatments for tuberculosis

Johnson & Johnson reported about promising clinical data for HIV vaccine

Johnson & Johnson today announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at its Janssen Pharmaceutical Companies

EU Commission authorized Johnson & Johnson’s acquisition of Actelion

As Johnson & Johnson’s proposal hit the news earlier this year in January, the company signed an acquisition agreement with Actelion Pharmaceuticals